Delaware | 94-3120386 | |
(State or other jurisdiction of | (IRS Employer | |
incorporation) | Identification No.) |
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
In the notice, Nasdaq stated that the Company may provide a plan to regain compliance with the continued listing requirements of The Nasdaq Global Market by May 6, 2013. Nasdaq will contact the Company with any questions or concerns regarding the plan. If Nasdaq accepts the plan, it can grant an extension of up to 180 calendar days from the date of the letter (that is, through September 16, 2013) to evidence compliance. If Nasdaq does not accept the plan, the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. Alternatively, the Company may consider applying to move to The Nasdaq Capital Market. The Company intends to submit a compliance plan with Nasdaq on or before May 6, 2013.
Stereotaxis, Inc. | ||||||||
Date: March 25, 2013 | By: | /s/ Karen Witte Duros | ||||||
Karen Witte Duros | ||||||||
Sr. Vice President, General Counsel | ||||||||